Jing Wang

Jing Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
NTNan Tang
Nan Tang
MPMengyue Pei
Mengyue Pei
HLHuihui Liu
Huihui Liu
JCJingru Chen
Jingru Chen
YWYouting Wang
Youting Wang
YGyuan gao
yuan gao
Background: The purpose of this study was to explore the relationship between infertility-related stress and dyadic coping with quality of life (QoL) in couples with infertility issues, and verify gender differences and dyadic interactions in the associations between them. Methods: This cross-sectional study included 340 couples who were recruited from the First Affiliated Hospital of Lanzhou University between March 2022 and November 2022. The Fertility Problem Inventory, Dyadic Coping Inventory and FertiQoL were used to measure infertility-related stress, dyadic coping and QoL. The Actor-Partner Interdependence Model was used to analyze the effects of infertility-related stress and dyadic coping on the couple’s own QoL (actor effect) as well as on their partner’s QoL (partner effect). Results: Female patients perceived significantly lower levels of QoL and dyadic coping than those of husbands. There was no statistically significant difference in the infertility-related stress between wives and husbands. Husbands’ infertility-related stress had actor and partner effects on their own and their wives’ QoL, while wives’ infertility-related stress only had an actor effect on their own QoL. Husbands’ dyadic coping had both actor effect and partner effects on their own and their wives’ QoL, meanwhile wives’ dyadic coping had both actor effect and partner effects on their own and their husbands’ QoL. Conclusion: Husbands’ QoL was impacted by their own infertility-related stress, dyadic coping and their wives’ dyadic coping. Whereas wives’ QoL was influenced by infertility-related stress and dyadic coping from both their own and their spouses. Therefore, elevating the level of dyadic coping may contribute to improving QoL for both husbands and wives. Moreover, enhancing the ability to cope with infertility-related stress might be useful for husbands and indirectly contribute to wives’ QoL.

19 March 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NTNan Tang
Nan Tang
LXLei Xie
Lei Xie
MPMengyue Pei
Mengyue Pei
JWJing Wang
Jing Wang
JHJunping Hu
Junping Hu
YGyuan gao
yuan gao
Background: We aimed to explore the influence of solution-focused approach (SFA) on anxiety and depression, sleep quality, quality of life and clinical pregnancy rate among women aged 35 or over undergoing in vitro fertilization-embryo transfer (IVF-ET). Methods: The study was performed at the reproductive center in a public hospital in Lanzhou city. Totally, 112 women were enrolled in this study, and were divided into group SFA (n = 56) and group control (n = 56). The patients in the group SFA completed five sessions (30 minutes/turn), and patients in the group control received routine care. Results: The intervention group showed a significant decrease in anxiety (t = 11.906, P < 0.001) and depression scores (t = 14.991, P < 0.001), as well as PSQI scores (t = 7.055, P < 0.001), and increased FertiQoL scores (t = -2.828, P < 0.001). Comparing the two groups after the intervention, the intervention group demonstrated significantly lower SAS scores (t = -10.348, P < 0.001), SDS scores (t = -8.416, P < 0.001), and PSQI scores (t = -5.087, P < 0.001), while FertiQoL scores were higher than the control group (t = 2.389, P = 0.019). The intervention group reported a satisfaction rate of 96.2% to 100% with the SFA. Conclusions: SFA can help relieve anxiety and depression, improve sleep quality and reproductive life quality. Improvement in psychological distress might not contribute to increasing female fecundity. Patients in the group SFA were satisfied with the intervention. Trial registration: Chinese Clinical Trial Registry (ChiCTR2300075444).